跳至主要内容
临床试验/NCT00855127
NCT00855127撤回不适用

Early Biomarkers of Acute Kidney Injury in Liver Transplant Patients

University of Colorado, Denver2 个研究点 分布在 1 个国家开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Development of acute kidney injury as defined by a 50% increase in serum creatinine

研究概览

简要总结

The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.

详细描述

Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 [IL-18] and urine neutrophil gelatinase associated lipocalin [NGAL]) can predict the outcome measures listed above.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First time liver transplant recipient
  • Cadaveric or living donor livers

排除标准

  • Unconscious patients or patients who cannot give consent
  • Pregnant women
  • Prisoners
  • Patients receiving dialysis before or during liver transplant operation
  • Patients receiving simultaneous liver-kidney transplants

结局指标

主要结局

Development of acute kidney injury as defined by a 50% increase in serum creatinine

时间窗: Within 2 to 5 days of liver transplant that is sustained for at least 24 hours

次要结局

  • The need for renal replacement therapy(After liver transplant operation to discharge)
  • Development of severe acute kidney injury, as defined as a doubling of serum creatinine(Within 2-5 days of transplant that is sustained for at least 24 hours)
  • All cause mortality(After liver transplant operation to discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验